DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 206075
describes CLOBETASOL PROPIONATE
, which is a drug marketed by Perrigo Israel, Taro, Wockhardt, Fougera Pharms, Akorn, Actavis Mid Atlantic, Perrigo Co, G And W Labs Inc, Glenmark Pharms, Mylan Pharms Inc, Teligent Pharma Inc, Novel Labs Inc, Tolmar, Zydus Pharms Usa Inc, Teva Pharms Usa, Fougera Pharms Inc, Paddock Llc, and Ingenus Pharms Llc, and is included in thirty-five NDAs. It is available from twenty-five suppliers. Additional details are available on the CLOBETASOL PROPIONATE profile page.
The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Pharmacology for NDA: 206075
Complete Access Available with Subscription
Summary for product number 001
|Approval Date:||Nov 23, 2015||TE:||AT||RLD:||No|
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.